Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

The drug provides both bronchodilation and anti ... and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

Supporters of Proposition 36 pitched the tough-on-crime measure, which California voters overwhelmingly approved in November, as an urgent solution to compel people struggling with addiction into ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... action available for the maintenance treatment of COPD in more than 20 years ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

According to the above data, the selective agonists of the GABA-A receptor complex are the drugs of first choice in the drug treatment of insomnia. [22] Once treatment has started, monitoring and ...